← Browse by Condition
Medical Condition

locally advanced esophageal adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05651594 Phase 2
Recruiting

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Enrollment
40 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
View Trial →